...creatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trial Group. J Clin Oncol 2007;25:1960–6. 151.Van Cutsem E, Vervenne WL, Bennouna J, et al. Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer. J Clin Oncol 2009;27:2231–7. 152.Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2......